# High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB

> **NCT06261827** · NA · COMPLETED · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 160 (actual)

## Conditions studied

- Nosocomial Pneumonia

## Interventions

- **DRUG:** Sham treatment
- **DRUG:** 200-ppm NO

## Key facts

- **NCT ID:** NCT06261827
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-20
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-10-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06261827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06261827, "High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06261827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
